Literature DB >> 20167003

Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?

Sónia C Correia1, Renato X Santos, Susana Cardoso, Cristina Carvalho, Maria S Santos, Catarina R Oliveira, Paula I Moreira.   

Abstract

Over the last decades estrogen has been recognized to be involved in normal brain function due to its neurothrophic and neuroprotective effects. Estrogen is intimately associated with neuronal survival, mitochondrial function, neuroinflammation and cognition through genomic as well as non-genomic pathways. It is also known that the neuroprotective actions mediated by estrogens are interlinked with the insulin-like growth factor-1 (IGF-1) signaling pathway. This review is mainly devoted to explore the physiological and pathophysiological effects of estrogen and its signaling pathways in the brain. The molecular mechanisms underlying these effects are also debated. Finally, we discuss the potential neuroprotection afforded by estrogens in Alzheimer's disease pathophysiology focusing in the "window of opportunity" for the initiation of estrogen therapy as a critical factor in the fight against neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167003     DOI: 10.2174/1874609811003020113

Source DB:  PubMed          Journal:  Curr Aging Sci        ISSN: 1874-6098


  27 in total

Review 1.  Nonhuman primate models of Alzheimer-like cerebral proteopathy.

Authors:  Eric Heuer; Rebecca F Rosen; Amarallys Cintron; Lary C Walker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Membrane-initiated estradiol actions mediate structural plasticity and reproduction.

Authors:  Paul Micevych; Amy Christensen
Journal:  Front Neuroendocrinol       Date:  2012-07-22       Impact factor: 8.606

Review 3.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

4.  Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study.

Authors:  Hyun Gi Kim; Na-Young Shin; Yunjin Bak; Kyung Ran Kim; Young-Chul Jung; Kyunghwa Han; Seung-Koo Lee; Soo Mee Lim
Journal:  Eur Radiol       Date:  2016-11-23       Impact factor: 5.315

5.  An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.

Authors:  Anna E Tschiffely; Rosemary A Schuh; Katalin Prokai-Tatrai; Mary Ann Ottinger; Laszlo Prokai
Journal:  Horm Behav       Date:  2017-12-22       Impact factor: 3.587

Review 6.  Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.

Authors:  Jelena Osmanovic-Barilar; Melita Salkovic-Petrisi
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

7.  Estrogen receptor-β of microglia underlies sexual differentiation of neuronal protection via ginsenosides in mice brain.

Authors:  Seungyeop Lee; Si-On Lee; Gyu-Lee Kim; Dong-Kwon Rhee
Journal:  CNS Neurosci Ther       Date:  2018-03-09       Impact factor: 5.243

8.  Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia N Starkova; Lichuan Yang; Anatoly A Starkov; Flint Beal
Journal:  FASEB J       Date:  2011-08-08       Impact factor: 5.191

9.  Prefrontal cortex and executive function impairments in primary breast cancer.

Authors:  Shelli R Kesler; Jamie S Kent; Ruth O'Hara
Journal:  Arch Neurol       Date:  2011-11

10.  Estrogen prevents high-glucose-induced damage of retinal ganglion cells via mitochondrial pathway.

Authors:  Ming Hao; Yue Li; Wenjian Lin; Qian Xu; Ning Shao; Yixin Zhang; Hongyu Kuang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-13       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.